Contributing to a world free from vaccine preventable diseases.

We increase the access to, and use of, vaccines by supporting public and nonprofit clients in developing better policies, products and tools that strengthen immunisation and disease control programmemes.

Our Projects

A world where everyone enjoys a life free from vaccine-preventable diseases.

Explore Our Work

Vaccines are responsible for preventing an estimated 2-3 million deaths per year whilst 1.5 million people worldwide are still dying from vaccine preventable diseases.

Using our public health experience and implementation and academic backgrounds, we assemble the optimal team to ensure that all immunisation programmemes are gifted the best chance of success.

Service Offerings

Access

Enable improved access to vaccines and diagnostic products.

Programme Implementation

Support the effective implementation of immunisation and diagnostic programmemes.

Policy and Strategy

Strengthen disease control policies and strategies by advising on their development

Evaluation

Conduct evaluations for the productive and beneficial functioning of organisations and activities in the vaccine ecosystem
View All Projects

Latest Publications

Partnerships are fundamental to progress in immunization, and this is especially true for human papillomavirus (HPV) vaccination, which must be delivered in the context of a broader immunization, sexual and reproductive health, and cervical cancer prevention...
Publication
Vaccine
View Publication
Pharyngitis, more commonly known as sore throat, is caused by viral and/or bacterial infections. Group A Streptococcus (Strep A) is the most common bacterial cause of pharyngitis. Strep A pharyngitis is an acute, self-limiting disease but...
Publication
Open Forum Infectious Diseases Volume 9, Issue 1, pp. S5-S14
View Publication
Impetigo is a highly contagious bacterial infection of the superficial layer of skin. Impetigo is caused by group A Streptococcus (Strep A) and Staphylococcus aureus, alone or in combination, with the former predominating in many tropical...
Publication
Open Forum Infectious Diseases Volume 9, Issue 1, pp. S15-S24
View Publication
Cellulitis is an acute bacterial infection of the dermis and subcutaneous tissue usually found complicating a wound, ulcer, or dermatosis. This article provides guidelines for the surveillance of cellulitis. The primary objectives of cellulitis surveillance are...
Publication
Open Forum Infectious Diseases Volume 9, Issue 1, pp. S25-S30
View Publication
Invasive group A streptococcal (Strep A) infections occur when Streptococcus pyogenes, also known as beta-hemolytic group A Streptococcus, invades a normally sterile site in the body. This article provides guidelines for establishing surveillance for invasive Strep...
Publication
Open Forum Infectious Diseases Volume 9, Issue 1, pp. S31-S40
View Publication
Acute rheumatic fever (ARF) is a multiorgan inflammatory disorder that results from the body’s autoimmune response to pharyngitis or a skin infection caused by Streptococcus pyogenes (Strep A). Acute rheumatic fever mainly affects those in low-...
Publication
Open Forum Infectious Diseases Volume 9, Issue 1, pp. S41-S49
View Publication
View All Publications

Latest Projects

Supporting the creation of a learning and performance management vision and market-shaping strategy

In partnership with Jhpiego, MMGH is supporting Gavi, the Vaccine Alliance to establish a set of global quality standards and requirements for the learning and performance management (LPM) approaches and solutions of frontline healthcare workers....
View Project

Strengthen Philippines Vaccine Manufacturing

In collaboration with a team of experts, MMGH is assisting The Asian Development Bank (ADB) to support the Department of Health and the Research Institute for Tropical Medicine (RITM) from Philippines in the pre-feasibility study and definition of a possible Public-Private Partnership for the creation of a vaccine manufacturing and...
View Project

Strategy for accelerated control of Japanese encephalitis in South East Asia

MMGH supported the WHO Regional Office for the Western Pacific in developing a guide for accelerating control of Japanese encephalitis (JE). The guide outlines regional targets, defines strategies and activities to accomplish these targets, and provides a framework for countries to develop national plans tailored to their situation. MMGH collaborated...
View Project
View All Projects

Our Clients

World Health Organisation

Disclaimer: The organisations shown here indicate supplier-client relationships. MMGH has no formal relationship with these organisations nor does this listing indicate any form of endorsement of MMGH’s work beyond the award of past or present contract(s).

Learn About Us

Our Story

We support public and non-profit clients in improving the implementation and evaluation of vaccine programmemes and products with the end goal of healthier populations, everywhere.

How We Do It

For each project, we assemble the optimal team. Drawing on our worldwide network of experts, we pull together the right blend of skills and knowledge to successfully complete each project.

Our Impact

For each project, we assemble the optimal team. Drawing on our worldwide network of experts, we pull together the right blend of skills and knowledge to successfully complete each project.

Learn More

Team Members in

6 cities

Clients in

12 countries

Research Conducted in

23 countries

For more on our latest projects, Follow us

Contact the MMGH Team

Headquarters:

MMGH Consulting GmbH
Kuerbergstrasse 1
8049 Zurich, Switzerland

+41 44 553 04 53

Branch:

MMGH Consulting GmbH
Chemin Maurice-Ravel 11C
1290 Versoix, Switzerland

+41 22 596 78 60